查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855661

儿科医疗保健市场：2025-2032年全球预测（按产品类型、疾病类型、年龄层、最终用户和分销管道划分）

Pediatric Health Market by Product Type, Disease Type, Age Group, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，儿科医疗保健市场将成长至 2,162.1 亿美元，复合年增长率为 8.37%。

关键市场统计数据
基准年 2024 1136.3亿美元
预计年份：2025年 1230.7亿美元
预测年份 2032 2162.1亿美元
复合年增长率 (%) 8.37%

这是一份策略性介绍，它为临床创新、不断发展的医疗服务以及正在重新定义儿科决策的商业要务提供了一个框架，这些决策将影响所有相关人员。

儿科医疗保健正处于一个关键的十字路口，临床创新、政策转变和不断发展的医疗服务模式正在汇聚，重塑实践和采购决策。本导言旨在向读者介绍贯穿报告的关键主题，包括诊断技术的进步、青少年生技药品和疫苗研发的日趋成熟、就地检验重要的作用，以及在不同环境下提供安全公平的儿科医疗保健的运营要务。阐明这些背景将有助于相关人员更好地理解后续的分析章节，并优先考虑能够带来可衡量的临床和组织价值的干预措施。

全面概述正在重塑儿科医疗服务体系的重大技术、监管和营运变革，以及相关人员的当务之急。

儿科医疗保健领域正经历着由技术进步、政策调整和不断变化的患者需求所驱动的重大变革。诊断技术的创新，例如先进的分子检测和即时检测平台，正使治疗更贴近床边和家庭，缩短诊断时间，并实现早期治疗性介入。同时，从微创成像系统到更智慧的监测工具，医疗设备的进步正在支持持续的个人化护理，同时降低弱势群体的手术风险。

分析和评估美国2025年对儿科医疗保健用品供应和采购征收关税的多方面营运和商业性影响

2025年对部分进口医疗产品加征的关税对儿科医疗保健体系、供应链经济和筹资策略产生了多方面的影响。关税带来的成本压力促使医疗服务提供者和经销商重新评估其供应商组合，重新评估设备和耗材的总拥有成本，并优先考虑能够降低关税波动风险的筹资策略。因此，采购团队越来越重视供应商多元化、近岸外包以及合约避险，以稳定价格和交货时间。

整合产品类型、疾病类别、患者人口统计资讯、医疗机构和分销管道等可操作的细分信息，以指导精准策略。

对产品、疾病、年龄、最终用户和分销管道细分的深入理解，对于使临床开发和商业策略与实际应用路径保持一致至关重要。按产品类型划分，医疗器材包括影像、监测和手术器材；诊断产品包括分子诊断和照护现场平台；药品包括生物製药、小分子药物和疫苗。每个类别都有其独特的临床应用情境、采购週期和监管考量，这些都会影响相关人员的参与和投资优先顺序的确定。同时，内分泌、胃肠病、传染病、神经病变和呼吸系统疾病等不同疾病类别对诊断、治疗方法和专用设备的需求也各不相同。在感染疾病领域，细菌、寄生虫和病毒病因导致诊断流程和治疗方法的差异，其中细菌亚型（如葡萄球菌和链球菌感染疾病）和感染疾病亚型（如呼吸道融合细胞病毒和轮状病毒）需要不同的预防和治疗策略。

区域对比分析重点阐述了支付方框架、法规环境和基础设施的差异如何影响全球儿科医疗保健的普及。

区域动态影响着儿科医疗保健的取得、应用和策略重点，美洲、欧洲、中东和非洲以及亚太地区在支付方结构、管理体制和医疗服务规范方面存在显着差异。在美洲，市场成熟度和对儿科专科护理的投资支持了先进诊断和治疗方法的快速应用，而报销机制的复杂性和城乡差异则影响着系统层面的应用。在欧洲、中东和非洲，区域​​性监管协调工作和不同的公共卫生优先事项可能导致各国疫苗和先进生技药品的普及曲线有显着差异。

企业策略和竞争定位洞察，重点在于阐述整合产品、伙伴关係以及小儿科特定监管专业知识如何推动产品采纳和差异化。

儿科领域的竞争行为和企业策略体现了产品系列深度、监管专业知识以及连接临床开发和终端用户应用的伙伴关係。领先企业透过整合仪器、诊断和治疗支援服务的一体化解决方案脱颖而出，简化临床工作流程并降低应用门槛。与学术中心、儿科医院和分销合作伙伴的策略联盟能够实现快速的临床检验和部署，而对临床医生培训和客户支援的投入则有助于实现持续应用。

为医疗保健领导者提供切实可行的优先建议，以加快儿科创新技术的应用，同时增强供应链韧性并促进相关人员的协作。

致力于加速儿科医疗领域变革的行业领导者应采取一系列务实且以证据为依据的行动，使商业性计划与临床实际情况相符。能够证明工作流程效率、安全性和病患体验得到改善的证据，能够引起临床医生和采购方的共鸣。接下来，他们投资于灵活的分销和定价模式，以满足从小儿科医院到居家照护机构等各类终端用户的需求，从而减少采购摩擦，扩大患者就医管道。此外，透过供应商多元化和紧急计画来增强供应链韧性，可以减轻贸易政策变化和物流限制带来的衝击。

结合相关人员访谈、文献综合和情境分析的稳健混合方法研究途径，为儿科医疗保健决策提供了可重复的研究结果。

本执行摘要的调查方法结合了第一手资料和第二手资料，旨在全面、可重复地理解儿科医疗保健的动态变化。第一手资料包括对临床医生、采购负责人、医院管理人员、监管专家和供应链经理进行结构化访谈和咨询，以获取关于采纳驱动因素、临床工作流程和营运限制的第一手观点。这些定性见解与第二手资料（包括同侪审查的临床文献、政策文件、监管指南和公司披露资讯）进行三角验证，以确保事实准确性，并将相关人员的意见置于既有证据的框架内。

简洁的结论将技术、营运和政策趋势与实现儿科患者疗效可衡量改进的策略要务联繫起来。

摘要：儿科医疗保健正受到诊断、器械创新、治疗和医疗服务模式等多方面趋势的交织影响而再形成。这些趋势既为临床领导者、医疗服务提供者和政策制定者带来了机会，也带来了挑战。分散式诊断和器械小型化使得早期介入和院外医疗服务得以扩展，而治疗方法的进步则需要对相关法规和临床路径进行调整，以确保各年龄层患者的安全性和有效性。贸易政策和供应链需求的变化进一步增加了规划的复杂性，因此，积极主动的筹资策略和在地化适应能力对于保障医疗服务的连续性至关重要。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 远端医疗平台在儿科慢性病管理和监测的应用日益广泛
  • 基于肠道菌丛分析的个人化儿科营养解决方案的拓展
  • 透过将人工智慧诊断技术应用于儿科皮肤病学，实现疾病的早期发现
  • 能够快速检测免疫球蛋白E的家用儿童过敏检测套组需求激增
  • 穿戴式生物感测器正逐渐应用于儿科水合状态和电解质失衡的连续监测。
  • 增加对儿科心理健康应用程式的投资，重点关注认知行为疗法技术
  • 区块链技术在儿童免疫记录安全管理的应用

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的儿科医疗市场

  • 装置
    • 诊断影像设备
    • 监测设备
    • 手术器械
  • 诊断试剂
    • 分子诊断
    • 照护现场
  • 製药
    • 生技药品
    • 低分子
    • 疫苗

第九章 依疾病类型分類的儿科医疗市场

  • 内分泌
  • 消化系统
  • 感染疾病
    • 细菌
      • 葡萄球菌感染疾病
      • 链球菌感染疾病
    • 寄生虫
      • 疟疾
    • 病毒性的
      • 呼吸道融合细胞病毒
      • 轮状病毒
  • 神经病学
  • 呼吸系统

第十章 依年龄组别分類的儿科医疗市场

  • 青春期
    • 青春期早期
    • 青春期后期
  • 孩子们
    • 幼儿期
    • 童年
  • 婴幼儿
  • 婴儿

第十一章 以最终用户分類的儿科医疗市场

  • 诊所
    • 多专科诊所
    • 小儿科诊所
  • 居家照护
  • 医院
    • 综合医院
    • 小儿科医院
  • 专业中心

第十二章 儿科医疗市场（依分销管道划分）

  • 医院药房
  • 网路药房
  • 零售药房

第十三章 各地区的儿科医疗市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 儿科医疗市场（依团体划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国儿科医疗保健市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Johnson & Johnson
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd
    • Merck & Co., Inc.
    • Novartis AG
    • Sanofi SA
    • GlaxoSmithKline plc
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Baxter International Inc.
Product Code: MRR-62667ADF93FE

The Pediatric Health Market is projected to grow by USD 216.21 billion at a CAGR of 8.37% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 113.63 billion
Estimated Year [2025] USD 123.07 billion
Forecast Year [2032] USD 216.21 billion
CAGR (%) 8.37%

A strategic introduction framing clinical innovation, care delivery evolution, and operational imperatives that are redefining pediatric health decision-making across stakeholders

Pediatric health is at a pivotal juncture where clinical innovation, policy shifts, and evolving care delivery models converge to reshape practice and procurement decisions. This introduction orients readers to the critical themes that thread through the report: advances in diagnostic modalities, the maturation of biologics and vaccine development for younger cohorts, the rising role of point-of-care testing, and the operational imperatives of delivering safe, equitable pediatric care across diverse settings. By establishing this context, stakeholders can better interpret the analytical chapters that follow and prioritize interventions that deliver measurable clinical and organizational value.

Emerging technologies and changing epidemiology are altering clinical pathways, which in turn influence purchasing priorities, staffing models, and supply chain resilience. These dynamics demand agile decision-making and a clear understanding of how product families-ranging from imaging and monitoring devices to molecular diagnostics and novel therapeutics-interact with disease burdens and care settings. With that framework in place, the remainder of the summary drills into structural shifts, regulatory and trade headwinds, segmentation nuances, regional contrasts, competitive behavior, and recommended actions to help leaders translate insight into outcomes.

Taken together, the introduction is designed to prime multidisciplinary audiences-clinicians, health system executives, commercial leaders, and policymakers-on the core forces shaping pediatric health, thereby enabling a shared baseline for subsequent, data-driven discussion and decision-making.

Comprehensive overview of the major technological, regulatory, and operational shifts reshaping pediatric healthcare delivery and stakeholder priorities in the near term

The pediatric health landscape is undergoing transformative shifts driven by technological advancement, policy recalibration, and changing patient needs. Diagnostic innovation is moving care closer to the bedside and home through refined molecular assays and point-of-care platforms, thereby compressing diagnostic timelines and enabling earlier therapeutic interventions. Concurrently, device evolution-ranging from less invasive imaging systems to smarter monitoring tools-supports continuous, individualized care while reducing procedural risk for vulnerable populations.

At the same time, drug development is accelerating along distinct trajectories, with biologics and vaccine technologies advancing specificity and safety profiles for younger age groups. Regulatory frameworks are adapting to accommodate pediatric-focused clinical programs, but heterogeneity in approval pathways and reimbursement mechanisms continues to shape adoption speed. Operationally, care delivery is decentralizing: hospitals, clinics, specialty centers, and home care are rebalancing responsibilities, and this redistribution of care necessitates interoperable technologies, flexible distribution channels, and clinician training programs tailored to pediatric needs.

These shifts are interconnected and cumulative. For example, the deployment of point-of-care diagnostics in home care settings amplifies the value proposition of therapeutic regimens that can be administered or monitored remotely. Likewise, improvements in monitoring devices enhance post-procedural safety and support shorter hospital stays. Together, these dynamics are reinventing clinical workflows, supplier relationships, and investment priorities across the pediatric health ecosystem.

Analytical assessment of the multifaceted operational and commercial repercussions stemming from 2025 United States tariff measures on pediatric healthcare supply and procurement

The implementation of tariffs enacted in 2025 on certain imported medical goods has produced layered effects across pediatric care pathways, supply chain economics, and procurement strategies. Tariff-induced cost pressures have prompted healthcare providers and distributors to reassess supplier mixes, reevaluate total cost of ownership for devices and consumables, and prioritize sourcing strategies that reduce exposure to tariff volatility. As a result, procurement teams have increasingly emphasized supplier diversification, nearshoring options, and contractual hedges to stabilize pricing and delivery timelines.

Clinically, these shifts have influenced equipment replacement cycles and the adoption timing for capital-intensive technologies. Hospitals and specialty centers are weighing trade-offs between immediate capital outlays and longer-term maintenance or service agreements. In parallel, manufacturers and distributors are reconfiguring logistics footprints and considering alternative production strategies to mitigate tariff impacts, including relocating certain manufacturing steps or adjusting bill-of-materials sourcing to qualify products for preferential trade treatments.

Policy responses and commercial countermeasures have emerged to preserve access to critical pediatric technologies. Regulatory waivers, temporary import concessions for essential pediatric supplies, and collaborative procurement initiatives have been deployed in select jurisdictions to limit disruptions. Consequently, stakeholders must balance short-term operational adaptations with strategic planning that anticipates continued trade policy uncertainty, ensuring continuity of care while managing the economic implications for pediatric service delivery.

Actionable segmentation intelligence that integrates product types, disease categories, patient age cohorts, care settings, and distribution channels to guide targeted strategies

A nuanced understanding of product, disease, age, end-user, and distribution channel segmentation is essential for aligning clinical development and commercial strategies with real-world adoption pathways. When product types are disaggregated, devices encompass imaging devices, monitoring devices, and surgical instruments, diagnostics include molecular diagnostics and point-of-care platforms, and drugs span biologics, small molecules, and vaccines; each category carries distinct clinical use-cases, procurement cycles, and regulatory considerations that affect how stakeholders prioritize engagement and investment. In parallel, disease categories such as endocrine, gastrointestinal, infectious, neurology, and respiratory conditions display heterogeneous demands for diagnostics, therapeutic modalities, and specialized equipment. Within infectious disease, bacterial, parasitic, and viral etiologies create differential diagnostic workflows and treatment regimens, with bacterial subtypes like staphylococcal and streptococcal infections and viral targets such as respiratory syncytial virus and rotavirus requiring tailored prevention and treatment strategies.

Age group segmentation further refines opportunity and risk assessment: adolescents, children, infants, and toddlers present distinct clinical profiles and dosing or device usability considerations, and subcategories including early and late adolescents as well as stages of early and middle childhood influence patient engagement and care pathways. End users-clinics, home care, hospitals, and specialty centers-each operate under different operational constraints and purchasing authorities; clinics vary between multi-specialty and pediatric-focused models, and hospitals differentiate between general and pediatric institutions, all of which affects procurement timelines and training needs. Finally, distribution channels such as hospital pharmacies, online pharmacies, and retail pharmacies determine availability, reimbursement complexity, and patient accessibility. By integrating these segmentation lenses, stakeholders can create precision-aligned go-to-market plans, tailor clinical evidence generation to the priorities of key buyer cohorts, and design distribution models that enhance uptake while addressing the specific needs of pediatric populations.

Comparative regional analysis highlighting how payer frameworks, regulatory environments, and infrastructure variances shape pediatric healthcare adoption across global regions

Regional dynamics shape access, adoption, and strategic prioritization in pediatric health, with marked differences in payer structures, regulatory regimes, and care delivery norms across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, market maturity and investment in pediatric specialty care support rapid adoption of advanced diagnostics and therapeutics, but reimbursement complexities and urban-rural disparities influence implementation at the system level. Transitioning to Europe, Middle East & Africa, region-specific regulatory harmonization efforts and varied public health priorities mean that adoption curves for vaccines and advanced biologics can differ substantially across countries, while supply chain resilience and local manufacturing capacity play outsized roles in continuity of care.

Across Asia-Pacific, demographic trends, burgeoning investments in healthcare infrastructure, and an expanding diagnostics ecosystem create opportunities for scalable deployment of point-of-care technologies and telehealth-enabled monitoring. However, heterogeneity within the region-ranging from high-resource urban centers to resource-constrained rural areas-necessitates differentiated engagement models and pricing strategies. Inter-regionally, cross-border partnerships, clinical collaboration networks, and technology transfer initiatives are increasingly important mechanisms for spreading best practices and accelerating diffusion of pediatric innovations. Stakeholders must therefore align regional market entry and expansion strategies with local regulatory requirements, procurement routines, and clinical practice patterns to achieve sustainable adoption.

Insights into corporate strategies and competitive positioning that reveal how integrated offerings, partnerships, and pediatric-focused regulatory expertise drive adoption and differentiation

Competitive behavior and company strategies in pediatric health reflect a combination of product portfolio depth, regulatory expertise, and partnerships that bridge clinical development with end-user adoption. Leading firms are differentiating through integrated solutions that combine devices, diagnostics, and therapeutic support services which simplify clinical workflows and lower barriers to adoption. Strategic alliances with academic centers, pediatric specialty hospitals, and distribution partners enable rapid clinical validation and deployment, while investments in clinician training and customer support underpin sustained utilization.

Many companies are pursuing modular product designs and service contracts that address capital constraints faced by hospitals and clinics, and they are emphasizing post-market evidence generation to demonstrate safety and real-world effectiveness in younger populations. At the same time, smaller, specialized firms are leveraging focused innovations-such as novel point-of-care assays or minimally invasive monitoring systems-to create niche footholds that larger organizations may later scale. Across competitors, there is a growing emphasis on regulatory agility, with dedicated pediatric development teams and adaptive trial designs intended to optimize timelines and address age-specific endpoints. These strategic patterns indicate that success will increasingly depend on cross-functional capabilities that integrate clinical evidence, regulatory navigation, commercialization, and after-sales support tailored to pediatric stakeholders.

Practical and prioritized recommendations for healthcare leaders to accelerate pediatric innovation adoption while strengthening supply resilience and stakeholder alignment

Industry leaders seeking to accelerate impact in pediatric health should adopt a set of pragmatic, evidence-centered actions that align commercial planning with clinical realities. First, prioritize cross-disciplinary clinical evidence programs that generate data relevant to multiple buyer groups: evidence that demonstrates improvements in workflow efficiency, safety, and patient experience will resonate with clinicians and purchasers alike. Next, invest in flexible distribution and pricing models that accommodate the diversity of end users-from pediatric hospitals to home care providers-to reduce friction in procurement and broaden patient access. Additionally, strengthening supply chain resilience through supplier diversification and contingency planning can mitigate disruptions stemming from trade policy shifts or logistics constraints.

Leaders should also cultivate strategic partnerships with pediatric centers of excellence and regional stakeholders to accelerate clinical adoption and co-develop training curricula that address device usability and diagnostic interpretation. Emphasizing interoperability and integration with electronic health records and telehealth platforms will facilitate data continuity and support longitudinal care pathways. Finally, adopt a phased commercial roll-out that pairs early adopter engagement with robust post-implementation monitoring, so that lessons from initial deployments inform broader scaling and continuous improvement initiatives. Collectively, these recommendations can reduce adoption barriers, optimize resource allocation, and increase the probability of sustained clinical and commercial success in pediatric health.

Robust mixed-methods research approach blending stakeholder interviews, literature synthesis, and scenario analysis to produce reproducible insights for pediatric healthcare decisions

The research methodology underpinning this executive summary combines primary and secondary approaches to deliver a comprehensive, reproducible understanding of pediatric health dynamics. Primary research involved structured interviews and consultations with clinicians, procurement leaders, hospital administrators, regulatory specialists, and supply chain managers to capture first-hand perspectives on adoption drivers, clinical workflows, and operational constraints. These qualitative insights were triangulated with secondary research comprising peer-reviewed clinical literature, policy documents, regulatory guidance, and company disclosures to ensure factual accuracy and to contextualize stakeholder inputs within established evidence.

Analytical techniques included thematic coding of qualitative interviews to identify common barriers and enablers, cross-sectional mapping of product-disease-use case alignments, and scenario analysis to explore implications of trade and policy shifts. Throughout the process, an emphasis was placed on reproducibility: sources were validated, assumptions were documented, and sensitivity to regional and end-user heterogeneity was explicitly considered. Ethical research practices guided stakeholder engagement and data handling, and findings were peer-reviewed by clinical and commercial subject matter experts to enhance robustness and relevance for decision-makers.

Concise concluding synthesis that ties technological, operational, and policy trends to strategic imperatives for achieving measurable improvements in pediatric patient outcomes

In summary, pediatric health is being reshaped by intersecting trends in diagnostics, device innovation, therapeutics, and care delivery models. These forces create both opportunities and complexities for clinical leaders, suppliers, and policymakers. Diagnostic decentralization and device miniaturization are enabling earlier intervention and expanded care beyond hospital walls, while therapeutic advances demand tailored regulatory and clinical pathways to ensure safety and efficacy across age groups. Trade policy shifts and supply chain imperatives further complicate planning, making proactive procurement strategies and regional adaptability essential for continuity of care.

Decision-makers should therefore prioritize integrated evidence generation, flexible commercialization strategies, and strategic partnerships that accelerate clinical adoption while mitigating operational risk. By aligning product development with the nuanced segmentation of product types, disease categories, age cohorts, care settings, and distribution channels, organizations can improve the likelihood of successful deployment and measurable clinical impact. Ultimately, the path forward requires coordinated efforts across clinical, commercial, and policy stakeholders to ensure that innovations meaningfully improve pediatric outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of telehealth platforms for pediatric chronic disease management and monitoring
  • 5.2. Expansion of personalized pediatric nutrition solutions informed by gut microbiome profiling
  • 5.3. Integration of artificial intelligence diagnostics in pediatric dermatology for early condition detection
  • 5.4. Surge in demand for at-home pediatric allergy testing kits with rapid immunoglobulin E detection
  • 5.5. Emergence of wearable biosensors for continuous pediatric hydration and electrolyte imbalance monitoring
  • 5.6. Rising investment in pediatric mental health apps focusing on cognitive behavioral therapy techniques
  • 5.7. Adoption of blockchain technology for secure pediatric immunization record management across providers

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pediatric Health Market, by Product Type

  • 8.1. Devices
    • 8.1.1. Imaging Devices
    • 8.1.2. Monitoring Devices
    • 8.1.3. Surgical Instruments
  • 8.2. Diagnostics
    • 8.2.1. Molecular Diagnostics
    • 8.2.2. Point Of Care
  • 8.3. Drugs
    • 8.3.1. Biologics
    • 8.3.2. Small Molecule
    • 8.3.3. Vaccines

9. Pediatric Health Market, by Disease Type

  • 9.1. Endocrine
  • 9.2. Gastrointestinal
  • 9.3. Infectious
    • 9.3.1. Bacterial
      • 9.3.1.1. Staphylococcal Infections
      • 9.3.1.2. Streptococcal Infections
    • 9.3.2. Parasitic
      • 9.3.2.1. Malaria
    • 9.3.3. Viral
      • 9.3.3.1. Respiratory Syncytial Virus
      • 9.3.3.2. Rotavirus
  • 9.4. Neurology
  • 9.5. Respiratory

10. Pediatric Health Market, by Age Group

  • 10.1. Adolescents
    • 10.1.1. Early Adolescents
    • 10.1.2. Late Adolescents
  • 10.2. Children
    • 10.2.1. Early Childhood
    • 10.2.2. Middle Childhood
  • 10.3. Infants
  • 10.4. Toddlers

11. Pediatric Health Market, by End User

  • 11.1. Clinics
    • 11.1.1. Multi Specialty Clinics
    • 11.1.2. Pediatric Clinics
  • 11.2. Home Care
  • 11.3. Hospitals
    • 11.3.1. General Hospitals
    • 11.3.2. Pediatric Hospitals
  • 11.4. Specialty Centers

12. Pediatric Health Market, by Distribution Channel

  • 12.1. Hospital Pharmacies
  • 12.2. Online Pharmacies
  • 12.3. Retail Pharmacies

13. Pediatric Health Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pediatric Health Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pediatric Health Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Johnson & Johnson
    • 16.3.2. Pfizer Inc.
    • 16.3.3. F. Hoffmann-La Roche Ltd
    • 16.3.4. Merck & Co., Inc.
    • 16.3.5. Novartis AG
    • 16.3.6. Sanofi S.A.
    • 16.3.7. GlaxoSmithKline plc
    • 16.3.8. Abbott Laboratories
    • 16.3.9. Becton, Dickinson and Company
    • 16.3.10. Baxter International Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. PEDIATRIC HEALTH MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. PEDIATRIC HEALTH MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PEDIATRIC HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY IMAGING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY IMAGING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY IMAGING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY IMAGING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY IMAGING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY IMAGING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY POINT OF CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BIOLOGICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SMALL MOLECULE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SMALL MOLECULE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SMALL MOLECULE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SMALL MOLECULE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ENDOCRINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ENDOCRINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ENDOCRINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ENDOCRINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ENDOCRINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STAPHYLOCOCCAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STAPHYLOCOCCAL INFECTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STAPHYLOCOCCAL INFECTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STAPHYLOCOCCAL INFECTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STAPHYLOCOCCAL INFECTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STAPHYLOCOCCAL INFECTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STREPTOCOCCAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STREPTOCOCCAL INFECTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STREPTOCOCCAL INFECTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STREPTOCOCCAL INFECTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STREPTOCOCCAL INFECTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STREPTOCOCCAL INFECTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MALARIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MALARIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MALARIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MALARIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MALARIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MALARIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY SYNCYTIAL VIRUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY SYNCYTIAL VIRUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY SYNCYTIAL VIRUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY SYNCYTIAL VIRUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY SYNCYTIAL VIRUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY SYNCYTIAL VIRUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ROTAVIRUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ROTAVIRUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ROTAVIRUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ROTAVIRUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ROTAVIRUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ROTAVIRUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY ADOLESCENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY ADOLESCENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY ADOLESCENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY ADOLESCENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY ADOLESCENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY LATE ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY LATE ADOLESCENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY LATE ADOLESCENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY LATE ADOLESCENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY LATE ADOLESCENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY LATE ADOLESCENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY CHILDHOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY CHILDHOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY CHILDHOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY CHILDHOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY CHILDHOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY CHILDHOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MIDDLE CHILDHOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MIDDLE CHILDHOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MIDDLE CHILDHOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MIDDLE CHILDHOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MIDDLE CHILDHOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MIDDLE CHILDHOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TODDLERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TODDLERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TODDLERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TODDLERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TODDLERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TODDLERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 299. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 302. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 303. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 304. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 305. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 306. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 307. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2024 (USD MILLION)
  • TABLE 310. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2025-2032 (USD MILLION)
  • TABLE 311. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
  • TABLE 312. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2025-2032 (USD MILLION)
  • TABLE 313. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2024 (USD MILLION)
  • TABLE 314. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2025-2032 (USD MILLION)
  • TABLE 315. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
  • TABLE 316. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2025-2032 (USD MILLION)
  • TABLE 317. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 318. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 319. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2024 (USD MILLION)
  • TABLE 320. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2025-2032 (USD MILLION)
  • TABLE 321. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2024 (USD MILLION)
  • TABLE 322. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2025-2032 (USD MILLION)
  • TABLE 323. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 324. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 325. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 326. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 327. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 328. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 329. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 330. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 331. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 336. NORTH AMERI